Hi kates,
News due Q1 2019:
-Travelan sales update (growth expected)
-NASH P2 study results, final report lodged with FDA
-C.diff trial enrollments completed and followed by results updates (its a short trial). Extremely positive results anticipated based on pre trial testing.
-Travelan FDA approval
So there is plenty of potentially positive news imminent.
Treatment for Clostridium-difficile Infection With IMM529, page-14
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.002(2.15%) |
Mkt cap ! $21.65M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.5¢ | $16.76K | 170.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50946 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 160371 | 2 |
View Market Depth
| Last trade - 15.34pm 06/09/2024 (20 minute delay) ? |
| IMC (ASX) Chart |